Rheum Disease in the Media Archives | Page 2 of 5 | Rheumatoid Arthritis Warrior

Rheumatoid Arthritis Awareness: Sugar Coat Cookies Please, Not a Disease

Why the sugar coating of Rheumatoid Arthritis in the media? Do you remember the insistence of Woman’s Day editors that patients were wrong and their article on Rheumatoid Arthritis was correct? The author later recanted, but the editor dug in repeatedly. That was three years ago and my first taste of the dogged commitment in the...Continue reading      72 Comments » Read more

Confusion & Blame Surround Methotrexate Shortages & Recalls

U.S. caught off guard by methotrexate shortage Shortages of injectable methotrexate began in 2010 and some sources say may continue through 2014. Many have been surprised that shortages of such inexpensive generic drugs could take Americans by surprise and continue for such an indefinite period. Finger-pointing at the FDA and drug companies is probably the one...Continue reading      41 Comments » Read more

Woman’s Day RA Is Destructive, but Phil & Venus Have Cred

In 2009, I first encountered something I called “the PR problem” with RA. For three years, I’ve disagreed with Woman’s Day magazine over whether the Woman’s Day version of RA is correct. On the blog, we’ve had discussions about various other fallacious articles on RA (some listed below). WebMD magazine offered a similar article last winter...Continue reading      37 Comments » Read more

Mind-boggling! – Aftermath of Tofacitinib FDA Hearing Part 2

After the FDA Arthritis Advisory Committee (AAC) hearing earlier this month for Pfizer’s new oral treatment for RA,  tofacitinib, we looked at the four distinct votes of the AAC and some of the ways the media responded to them. They ranged from serious to pitiful to laughable. But there’s more.     3 news bytes that might...Continue reading      14 Comments » Read more

Aftermath of the FDA Vote on Pfizer’s RA JAK Inhibitor, Tofacitinib

After the tofacitinib FDA hearing, the votes are in, false perceptions persist, and patients still need relief. Some estimate that tofacitinib could be approved by the US FDA within a few months after mixed votes and mostly inaccurate press reports. It’s fitting this discussion takes place as rawarrior.com begins its fourth year of reporting the patient...Continue reading      44 Comments » Read more

Consumer Reports’ Absurd Best Buy Rheumatoid Arthritis Drug List

RESPONSE TO Consumer Reports Health Best Buy Drugs; Evaluating Prescription Drugs Used to Treat the Symptoms of Rheumatoid Arthritis: The Biologics Warrior to Washington: Next week, I’m going to D.C. to make an oral presentation to the “Arthritis Advisory Committee” at a hearing about a new Rheumatoid Arthritis treatment, tofacitinib. I want you to know why...Continue reading      47 Comments » Read more
“imaware™
    Advertisement
Would You Like Free Email Updates?
Stay in touch with RA Warrior.
We respect your privacy. Your email address will never be shared.